QIYU BIOTECH
Qi Xiangdong, founder of Qiyu Bio, said: “Innovation is the starting and future of Qiyu Bio, and it is the core driving force of enterprise development. Qiyu Bio will use the first-class antibody technology platform to build superior biopharmaceutical pipelines and explore the field of biotherapy. A big breakthrough. With the development and improvement of the company, Qiyu will have core competitiveness in more fields.
QIYU BIOTECH
Industry:
Biotechnology Health Care Medical
Founded:
2017-07-01
Address:
Shanghai, Shanghai, China
Country:
China
Total Employee:
11+
Status:
Active
Total Funding:
31.4 M USD
Similar Organizations
Cagen Bio
Cagen Bio is a vitro diagnostic reagents developer.
Dima Biotech
Dima Biotech is a cancer immunotherapy and monoclonal antibody developer.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Virogin Biotech
Virogin Biotech is an antineoplastic drug developer.
Yusu Biotech
Yusu Biotech is a hair care products developer.
Investors List
Tririver Capital
Tririver Capital investment in Series B - Qiyu Biotech
Oriza Prior
Oriza Prior investment in Series B - Qiyu Biotech
BOCOM International
BOCOM International investment in Series B - Qiyu Biotech
Shanghai Pudong Science and Technology Investment
Shanghai Pudong Science and Technology Investment investment in Series B - Qiyu Biotech
Longmen Capital
Longmen Capital investment in Series B - Qiyu Biotech
Watson Investment
Watson Investment investment in Series A - Qiyu Biotech
Jundu Investment
Jundu Investment investment in Series A - Qiyu Biotech
More informations about "Qiyu Biotech"
Qiyu Biotech Company Profile 2024: Valuation, Funding …
Qiyu Biotech General Information Description. Developer of macromolecular biopharmaceutical drug designed to treat refractory cancers and autoimmune diseases. The company's platform include hybridoma antibody humanization …See details»
Qiyu Biotech - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 23, 2021: Series B - Qiyu …See details»
Qiyu Biotechnology (Shanghai) Co., Ltd. - Drug pipelines, Patents ...
Aug 3, 2024 Explore Qiyu Biotechnology (Shanghai) Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
QureBio - Products, Competitors, Financials, Employees, …
QureBio, also Qiyu Biotech, is a macromolecular biopharmaceutical research and development company specializing in macromolecular biopharmaceuticals. The company aims to develop …See details»
Shenzhen Qiyu Biotechnology Co., Ltd.: Drug pipelines, Patents ...
Jul 23, 2023 Explore Shenzhen Qiyu Biotechnology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Qiyu Biotechnology (Shanghai) Co., Ltd., a research and …
Recently, Qiyu Biotechnology (Shanghai) Co., Ltd. received tens of millions of yuan of pre-B round investment from New Henglida Capital and other related institutions. Founded in July …See details»
Qiyu Biotech - Crunchbase
Companies like Qiyu Biotech include Micot, Virogin Biotech, and Hua Medicine. Medtrum . Shanghai, Shanghai, China 5 Contacts 101-250 employees . Biotechnology . Health Care . …See details»
Guangzhou Qiyu Biotechnology Co., Ltd. - Drug pipelines, Patents ...
Last update 19 Sep 2024. Guangzhou Qiyu Biotechnology Co., Ltd. Private Company |See details»
Qiyu Biotech of Shanghai Completes A Funding Round …
Aug 14, 2019 Qiyu Biotechnology, a Shanghai startup located in Zhangjiang Hi-Tech Park, completed a Series A round that raised “tens of millions of RMB” from Jundu Investment and Wosheng Capital. This proceeds are earmarked to …See details»
Qiyu Biotech of Shanghai Completes A Funding Round for Novel …
Aug 14, 2019 Qiyu Biotechnology, a Shanghai startup located in Zhangjiang Hi-Tech Park, completed a Series A round that raised "tens of millions of RMB" from Jundu Investment and …See details»
Qiyu Biotechnology Co., Ltd. announced that it has received CNY …
Dec 22, 2021 Qiyu Biotechnology (Shanghai) Co., Ltd. announced that it has received nearly CNY 200 million in a round of funding led by BOCOM International Holdings Company Limited …See details»
Series B - Qiyu Biotech - 2021-12-23 - Crunchbase
Dec 23, 2021 Organization Name . Qiyu Biotech . Announced Date Dec 23, 2021; Funding Type ...See details»
Bozhou Qiyu Biotechnology Co., Ltd.: Drug pipelines, Patents, …
Dec 4, 2023 Explore Bozhou Qiyu Biotechnology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Guangzhou Qiyu Biotechnology Co., Ltd. - Member at AIHBA
At Guangzhou Qiyu Biotechnology Co., Ltd., we offer a diverse and carefully curated selection of products designed to enrich your daily health and beauty routine. Guangzhou Qiyu …See details»
Qiyu Biotechnology Co., Ltd. announced that it has received CNY …
Dec 22, 2021 Qiyu Biotechnology Co., Ltd. announced that it has received nearly CNY 200 million in a round of funding led by BOCOM International Holdings Company Limited on …See details»
Shanghai Qiyu Biotechnology Co., Ltd. - Drug pipelines, Patents ...
Last update 02 May 2024. Shanghai Qiyu Biotechnology Co., Ltd. 2021 |See details»
Hengrui Medicine's Apatinib and Qiyu Bio-Q-1802 announced a …
The product "Q-1802" is an innovative drug for the treatment of tumors developed by Qiyu Biotech. It is a double antibody that simultaneously targets Claudin 18.2 and PD-L1. Due o its …See details»